Designs for population pharmacodynamics: value of pharmacokinetic data and population analysis.
about
Lewis Sheiner ISoP/UCSF Lecturer Award: From Drug Use to Statistical Models and Vice VersaEvaluation of Bayesian estimation in comparison to NONMEM for population pharmacokinetic data analysis: application to pefloxacin in intensive care unit patients.A pharmacokinetic/pharmacodynamic model for a platelet activating factor antagonist based on data arising from Phase I studies.Screening for sources of interindividual pharmacokinetic variability in anticancer drug therapy: utility of population analysis.Population pharmacokinetics of amphotericin B lipid complex in neonates.Pharmacodynamic parameter estimation: population size versus number of samples.A pragmatic approach to the design of population pharmacokinetic studies.Population-based assessments of clinical drug-drug interactions: qualitative indices or quantitative measures?Pharmacokinetic and pharmacodynamic data and models in clinical trials.On the recording of sample times and parameter estimation from repeated measures pharmacokinetic data.Simultaneous population optimal design for pharmacokinetic-pharmacodynamic experiments.Children in clinical trials: towards evidence-based pediatric pharmacotherapy using pharmacokinetic-pharmacodynamic modeling.Design optimisation for pharmacokinetic modeling of a cocktail of phenotyping drugs.A limited sampling strategy based on maximum a posteriori Bayesian estimation for a five-probe phenotyping cocktail.Evolution of pharmacokinetics and pharmacokinetic/dynamic correlations during the 20th century.Design evaluation and optimisation in crossover pharmacokinetic studies analysed by nonlinear mixed effects models.FTY720, a novel immunomodulator in de novo kidney transplant patients: pharmacokinetics and exposure-response relationship.Bayesian design criteria: computation, comparison, and application to a pharmacokinetic and a pharmacodynamic model.An effective approach for obtaining optimal sampling windows for population pharmacokinetic experiments.Further developments of the Fisher information matrix in nonlinear mixed effects models with evaluation in population pharmacokinetics.Errors-in-variables in joint population pharmacokinetic/pharmacodynamic modeling.A two-step iterative algorithm for estimation in nonlinear mixed-effect models with an evaluation in population pharmacokinetics.Comparison of some practical sampling strategies for population pharmacokinetic studies.Design evaluation for a population pharmacokinetic study using clinical trial simulations: a case study.Gastric Emptying in Critically Ill Children.
P2860
Q28652486-C09D1617-136D-4BF7-B5B2-20BCF290B555Q30827141-9BC1470D-8407-466C-AFE7-E11EABB9670BQ30983125-A5DEB221-02AA-49B9-B124-EB4D4C9B66B4Q34211026-17F65F1D-6E01-454D-9E4A-5E1D70838B0AQ34228332-A068999F-F3DE-4315-A530-4E2305A0E44AQ36341561-11147BE9-0A61-48A8-97D0-D0C939002DC3Q36341611-BEDBA17D-6226-4A87-A791-29390D69CDC8Q36628026-5DC10EE2-B292-41EC-85B9-7C541526950EQ36765400-9D701C46-E122-4094-A167-8CB9CEB33755Q36883130-A3CF3575-DC84-4020-ABA2-639B734982CFQ37361446-6B9BD635-AB0E-4F10-9538-4D071FCD4A1CQ38857191-5AE021ED-F568-45CF-95B9-0657F595C881Q40186641-AC9F983D-B18B-437E-BB99-AC6EE619BEDFQ40405015-44CF2ECE-55FC-47FE-A104-803B2F3C3B33Q40749507-9FDAA052-A06D-438F-AC63-5535C2021947Q45241474-182B2E31-5604-4A70-8DBB-7B7245FA8A01Q46765994-DDCA5DEF-0BB3-4215-A095-6A2E409CDFADQ51650989-B9BD8B0E-3833-42A9-B1F0-201A3C4D9272Q51857180-7D0D3627-D478-4175-8159-D1C7C03DEEBEQ52017271-A5B26176-4D34-4EE0-A5CC-24615092A0B9Q52055397-EEE0E1D7-F895-40D0-8856-4B013BA4A961Q52337597-31EA39F9-6600-4AA8-B328-3E70062EC9D5Q52890298-7F2D5823-7442-491F-B750-F3B8397843AEQ52927314-324D3344-E55D-4147-B3A4-D6322E1E9ABAQ53589828-AE85EB74-91E8-4FFA-8E45-50C824D12E26
P2860
Designs for population pharmacodynamics: value of pharmacokinetic data and population analysis.
description
1991 nî lūn-bûn
@nan
1991 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Designs for population pharmac ...... data and population analysis.
@ast
Designs for population pharmac ...... data and population analysis.
@en
Designs for population pharmac ...... data and population analysis.
@pl
type
label
Designs for population pharmac ...... data and population analysis.
@ast
Designs for population pharmac ...... data and population analysis.
@en
Designs for population pharmac ...... data and population analysis.
@pl
prefLabel
Designs for population pharmac ...... data and population analysis.
@ast
Designs for population pharmac ...... data and population analysis.
@en
Designs for population pharmac ...... data and population analysis.
@pl
P2860
P356
P1476
Designs for population pharmac ...... data and population analysis.
@en
P2093
Hashimoto Y
Sheiner LB
P2860
P2888
P304
P356
10.1007/BF03036255
P577
1991-06-01T00:00:00Z
P6179
1050315024